Characterization of the Inflammatory Response to Severe COVID-19 Illness
Oliver J McElvaney,Natalie L McEvoy,Oisín F McElvaney,Tomás P Carroll,Mark P Murphy,Danielle M Dunlea,Orna Ní Choileáin,Jennifer Clarke,Eoin O'Connor,Grace Hogan,Daniel Ryan,Imran Sulaiman,Cedric Gunaratnam,Peter Branagan,Michael E O'Brien,Ross K Morgan,Richard W Costello,Killian Hurley,Seán Walsh,Eoghan de Barra,Cora McNally,Samuel McConkey,Fiona Boland,Sinead Galvin,Fiona Kiernan,James O'Rourke,Rory Dwyer,Michael Power,Pierce Geoghegan,Caroline Larkin,Ruth Aoibheann O'Leary,James Freeman,Alan Gaffney,Brian Marsh,Gerard F Curley,Noel G McElvaney,Oliver J. McElvaney,Natalie L. McEvoy,Oisín F. McElvaney,Tomás P. Carroll,Mark P. Murphy,Danielle M. Dunlea,Eoin O’Connor,Michael E. O’Brien,Ross K. Morgan,Richard W. Costello,James O’Rourke,Ruth Aoibheann O’Leary,Gerard F. Curley,Noel G. McElvaney
DOI: https://doi.org/10.1164/rccm.202005-1583OC
IF: 24.7
2020-09-16
American Journal of Respiratory and Critical Care Medicine
Abstract:Rationale: Coronavirus disease (COVID-19) is a global threat to health. Its inflammatory characteristics are incompletely understood. Objectives: To define the cytokine profile of COVID-19 and to identify evidence of immunometabolic alterations in those with severe illness. Methods: Levels of IL-1β, IL-6, IL-8, IL-10, and sTNFR1 (soluble tumor necrosis factor receptor 1) were assessed in plasma from healthy volunteers, hospitalized but stable patients with COVID-19 (COVID stable patients), patients with COVID-19 requiring ICU admission (COVID ICU patients), and patients with severe community-acquired pneumonia requiring ICU support (CAP ICU patients). Immunometabolic markers were measured in circulating neutrophils from patients with severe COVID-19. The acute phase response of AAT (alpha-1 antitrypsin) to COVID-19 was also evaluated. Measurements and Main Results: IL-1β, IL-6, IL-8, and sTNFR1 were all increased in patients with COVID-19. COVID ICU patients could be clearly differentiated from COVID stable patients, and demonstrated higher levels of IL-1β, IL-6, and sTNFR1 but lower IL-10 than CAP ICU patients. COVID-19 neutrophils displayed altered immunometabolism, with increased cytosolic PKM2 (pyruvate kinase M2), phosphorylated PKM2, HIF-1α (hypoxia-inducible factor-1α), and lactate. The production and sialylation of AAT increased in COVID-19, but this antiinflammatory response was overwhelmed in severe illness, with the IL-6:AAT ratio markedly higher in patients requiring ICU admission ( P < 0.0001). In critically unwell patients with COVID-19, increases in IL-6:AAT predicted prolonged ICU stay and mortality, whereas improvement in IL-6:AAT was associated with clinical resolution ( P < 0.0001). Conclusions: The COVID-19 cytokinemia is distinct from that of other types of pneumonia, leading to organ failure and ICU need. Neutrophils undergo immunometabolic reprogramming in severe COVID-19 illness. Cytokine ratios may predict outcomes in this population.
respiratory system,critical care medicine